Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.

Dafflon C, Craig VJ, Méreau H, Gräsel J, Schacher Engstler B, Hoffman G, Nigsch F, Gaulis S, Barys L, Ito M, Aguadé-Gorgorió J, Bornhauser B, Bourquin JP, Proske A, Stork-Fux C, Murakami M, Sellers WR, Hofmann F, Schwaller J, Tiedt R.

Leukemia. 2017 Jun;31(6):1269-1277. doi: 10.1038/leu.2016.327. Epub 2016 Nov 14.

PMID:
27840424
2.

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Craig VJ, Zhang L, Hagood JS, Owen CA.

Am J Respir Cell Mol Biol. 2015 Nov;53(5):585-600. doi: 10.1165/rcmb.2015-0020TR. Review.

3.

Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.

Craig VJ, Polverino F, Laucho-Contreras ME, Shi Y, Liu Y, Osorio JC, Tesfaigzi Y, Pinto-Plata V, Gochuico BR, Rosas IO, Owen CA.

PLoS One. 2014 May 14;9(5):e97485. doi: 10.1371/journal.pone.0097485. eCollection 2014.

4.

A structural basis for the regulation of the LIM-homeodomain protein islet 1 (Isl1) by intra- and intermolecular interactions.

Gadd MS, Jacques DA, Nisevic I, Craig VJ, Kwan AH, Guss JM, Matthews JM.

J Biol Chem. 2013 Jul 26;288(30):21924-35. doi: 10.1074/jbc.M113.478586. Epub 2013 Jun 9.

5.

Adam8 limits the development of allergic airway inflammation in mice.

Knolle MD, Nakajima T, Hergrueter A, Gupta K, Polverino F, Craig VJ, Fyfe SE, Zahid M, Permaul P, Cernadas M, Montano G, Tesfaigzi Y, Sholl L, Kobzik L, Israel E, Owen CA.

J Immunol. 2013 Jun 15;190(12):6434-49. doi: 10.4049/jimmunol.1202329. Epub 2013 May 13.

6.

Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, Owen CA.

J Immunol. 2013 Apr 15;190(8):4283-96. doi: 10.4049/jimmunol.1201043. Epub 2013 Mar 13.

7.

The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies.

Schmid CA, Craig VJ, Müller A, Flori M.

Curr Pharm Des. 2013;19(7):1201-10. Review.

PMID:
23092340
8.

Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.

Harbinski F, Craig VJ, Sanghavi S, Jeffery D, Liu L, Sheppard KA, Wagner S, Stamm C, Buness A, Chatenay-Rivauday C, Yao Y, He F, Lu CX, Guagnano V, Metz T, Finan PM, Hofmann F, Sellers WR, Porter JA, Myer VE, Graus-Porta D, Wilson CJ, Buckler A, Tiedt R.

Cancer Discov. 2012 Oct;2(10):948-59. doi: 10.1158/2159-8290.CD-12-0237. Epub 2012 Aug 8.

9.

Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo.

Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Müller A.

Leukemia. 2012 Nov;26(11):2421-4. doi: 10.1038/leu.2012.110. Epub 2012 Apr 23. No abstract available.

PMID:
22522790
10.

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.

Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, Rehrauer H, Schlapbach R, Dirnhofer S, Tzankov A, Müller A.

Blood. 2011 Jun 9;117(23):6227-36. doi: 10.1182/blood-2010-10-312231. Epub 2011 Apr 1.

11.

Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis.

Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T, Müller A.

Cancer Res. 2011 May 15;71(10):3616-24. doi: 10.1158/0008-5472.CAN-10-3907. Epub 2011 Mar 31.

12.

B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis.

Craig VJ, Cogliatti SB, Arnold I, Gerke C, Balandat JE, Wündisch T, Müller A.

Leukemia. 2010 Jun;24(6):1186-96. doi: 10.1038/leu.2010.76. Epub 2010 Apr 29.

PMID:
20428202
13.

Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.

Craig VJ, Arnold I, Gerke C, Huynh MQ, Wündisch T, Neubauer A, Renner C, Falkow S, Müller A.

Blood. 2010 Jan 21;115(3):581-91. doi: 10.1182/blood-2009-06-228015. Epub 2009 Nov 17.

14.

Competition between LIM-binding domains.

Matthews JM, Bhati M, Craig VJ, Deane JE, Jeffries C, Lee C, Nancarrow AL, Ryan DP, Sunde M.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1393-7. doi: 10.1042/BST0361393. Review.

PMID:
19021562
15.

Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes.

Bhati M, Lee C, Nancarrow AL, Lee M, Craig VJ, Bach I, Guss JM, Mackay JP, Matthews JM.

EMBO J. 2008 Jul 23;27(14):2018-29. doi: 10.1038/emboj.2008.123. Epub 2008 Jun 26.

Supplemental Content

Loading ...
Support Center